Inhibikase Therapeutics (IKT) null Earnings

31MarConfirmed
May 21
Aug 21
Nov 21
Mar 22
-0.38
-0.3
-0.22
-0.14

Details

Expected EPS
-0.17
Actual EPS
-0.2
Surprise EPS
-0.03
Surprise Percent
+17.65%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.2 per share for .

0 Comments

Share your thoughts